Synthetic Biology Market By Product type (Core Products, Enabling Products and Enabled Products), By Application (Healthcare, Agriculture, Chemicals and Others) and By Region- Trends, Analysis and Forecast till 2034

Synthetic Biology Market was valued at USD 14.5 Billion in 2024 and is projected to grow at a CAGR of 24.2% to reach USD 126.9 Billion by 2034.

Synthetic biology is the combination of science and engineering which is used in testing, construction, and designing of novel artificial organisms, cells etc. through combination of domains such as molecular biology, genetic engineering and evolutionary biology to modify or redesign existing natural biological systems. It integrates chemical synthesis of DNA with growing knowledge of genomics to empower researchers to quickly manufacture catalogued DNA sequences and fabricate them into new genomes that can be used in the production of advanced bio fuels, bio-products, renewable chemicals, bio-based specialty chemicals and in the health care sector as well.

Increasing involvement of government bodies

Increasing involvement of government bodies, research institutes, large-scale organizations and declining cost of DNA sequencing & synthesizing synthetic biology research activities, rising R&D funding drives the growth of the global synthetic biology market. Further, the increasing need for food owing to the increasing population and demand for synthetic genes and synthetic cells fosters the growth of global synthetic biology market. Moreover, advancement in genome engineering such as CRISPR and DNA synthesis technologies also enhances the growth of global synthetic biology market. However, bio-safety & bio-security, ethical issues related to misuse of synthetic biology and possibilities of accidental release of pathogens into free atmosphere hamper the growth of global synthetic biology market. In addition, complicated and irregular construction and testing process of biological systems restrains the growth of synthetic biology market.

This report segments Global synthetic market has been segmented on the basis of product type, application and region. On the basis of product type, the global synthetic biology market is segmented into core products (synthetic DNA, synthetic cells, synthetic genes and synthetic clones etc.) and enabling products (DNA synthesis and oligonucleotide synthesis). On the basis of technology, the global synthetic biology market is segmented into genome engineering, DNA sequencing, bioinformatics, biological components and integrated systems. On the basis of application, the global synthetic biology market is segmented into healthcare, agriculture, chemicals and others.

Regional Insights:

On the basis of region, the global synthetic biology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America holds the maximum share in the global synthetic biology market owing to the presence of advanced healthcare infrastructure, government investments, and major players in countries in this region. Asia Pacific and Europe on the basis of region are expected to hold significant shares in the growth of global synthetic biology market attributed to government participation and the increase in the funding for the development of synthetic biology over the forecast period.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Synthetic Biology Market report based on Product Type, Technology, Application and region:

Synthetic Biology Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa Synthetic biology Market, By Product type
    • Middle East & Africa Synthetic biology Market, By Technology
    • Middle East & Africa Synthetic biology Market, By Application
    • Middle East & Africa Synthetic biology Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Synthetic biology Market, By Product type
    • Latin America Synthetic biology Market, By Technology
    • Latin America Synthetic biology Market, By Application
    • Latin America Synthetic biology Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific Synthetic biology Market, By Product type
    • Asia Pacific Synthetic biology Market, By Technology
    • Asia Pacific Synthetic biology Market, By Application
    • Asia Pacific Synthetic biology Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific                                                                                                                                                                                         
  • Europe
    • Europe Synthetic biology Market, By Product type
    • Europe Synthetic biology Market, By Technology
    • Europe Synthetic biology Market, By Application
    • Europe Synthetic biology Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America Synthetic biology Market, By Product type
  • North America Synthetic biology Market, By Technology
  • North America Synthetic biology Market, By Application
  • North America Synthetic biology Market, By Country
    • U.S.
    • Canada

Key players operating in the global synthetic biology market includes Thermo Fischer Scientific, GenScript, Biosearch Technologies, Integrated DNA technologies, Eurofins Scientific, Inc., Origene technologies, Scientific genomics Inc., Editas Medicine, Inc., Pareto Biotechnologies and Syntrox Inc.

Key features of the study:

Prophecy Market Insights provides detailed analysis on synthetic biology market in our report- Global Synthetic biology Market by product type, application, and region. The report provides market size (USD Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, customers demand, and regional outlook. The report delivers competitive analysis about leading players in the global synthetic biology market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe. Various strategy matrices include in the report are PEST analysis, PORTER’s five forces analysis, and opportunity map analysis to analyze the synthetic biology market.

Recent Development:

• In January 2024, Rice University launched the Rice Synthetic Biology Institute, which aims to catalyze collaborative research in synthetic biology and its translation into technologies that benefit society. The Rice Synthetic Biology Institute demonstrates how everyone benefits when the top minds in natural sciences and engineering collaborate at a leading research university.
• In January 2024, Asimov, synthetic biology company, launched its new LV edge packaging system, claiming to improve the cost efficiency and reduce the supply chain risk of lentiviral production. The system minimizes GMP plasmid cost, process complexity, and supply chain risk by integrating viral genes into the host cell.

• Thermo Fischer Scientific
• GenScript
• Biosearch Technologies
• Integrated DNA technologies
• Eurofins Scientific, Inc.
• Origene technologies
• Scientific genomics Inc.
• Editas Medicine, Inc.
• Pareto Biotechnologies
• Syntrox Inc